Home   ->   news   ->   Press Releases

Press Releases

2013

News Archives: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

2013/12/23
Winners of WuXi PharmaTech Awards Inducted Into Prestigious Academies

2013/12/10
WuXi PharmaTech Presents 2013 Life Science and Chemistry Awards

2013/11/15
WuXi PharmaTech to Partner with Pharmacyclics

2013/11/12
WuXi PharmaTech Announces Third-Quarter 2013 Results

2013/11/07
WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2013 Annual General Meeting

2013/11/04
WuXi PharmaTech Announces Licensing Agreement for Patient-Derived Xenograft Models with Mayo Clinic’s Center for Individualized Medicine

2013/10/30
WuXi AppTec Successfully Completes Its First 2000L Disposable Bioreactor Run Using an NS0 Cell Line, Marking an Industry Milestone

2013/10/29
WuXi Manufacturing Facility Passes FDA Inspection

2013/10/16
WuXi AppTec Receives CLIA Certification for its Genomics Clinical Laboratory

2013/08/12
WuXi PharmaTech Announces Second-Quarter 2013 Results

2013/07/16
WuXiPRA Names James Pusey President and General Manager

2013/06/16
Ambrx and Zhejiang Medicine Co. Ltd. Form Collaboration to Develop and Commercialize Ambrx’s Antibody Drug Conjugate for Breast Cancer

2013/5/13
WuXi PharmaTech Announces First-Quarter 2013 Results

2013/4/1
Chinese Premier Li Keqiang Visits WuXi PharmaTech’s Headquarters in Shanghai

2013/3/13
WuXi PharmaTech Receives Letter from AAALAC Commending Animal Care at Suzhou Toxicology Facility as “Exemplary”

2013/3/7
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program

2013/3/5
WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies

2013/1/30
WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards